Neurointerventional Devices Market Global Analysis by Leading Players like Merit Medical Systems,Penumbra, Inc.,Rapid Medical,Microport Scientific Corporation. | Outlook till 2027

According to new market research titled ‘Neurointerventional Devices Market to 2027 – Global Analysis and Forecasts by Type, Technique and End User’. The global neurointerventional devices market is expected to reach US$ 4,524.34 Mn in 2027 from US$ 2,323.02 Mn in 2018. The market is projected to grow with a CAGR of 8.0% from 2019-2027. The report provides trends prevailing in the global neurointerventional devices market and the factors driving market and also the factors that act as hindrances.

Request a Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00005548/

The global Neurointerventional Devices Market, based on the technique, was segmented into neurothrombectomy, stenting, coiling procedure, cerebral angiography, and flow disruption. In 2018, the neurothrombectomy accounted for the largest market share in the global neurointerventional devices market by technique. Technological development in neurothrombectomy procedures and its high acceptance by healthcare professionals are the major factors driving the growth of the segment. The primary factor for the growth of the market is the increasing adoption of neurothrombectomy techniques.

Topmost Vendors:

1. Merit Medical Systems
2. Penumbra, Inc.
3. Rapid Medical
4. Microport Scientific Corporation
5. InspireMD, Inc.
6. Medtronic
7. Stryker Corporation
8. iVascular S.L.U.
9. Terumo Corporation
10. Boston Scientific Corporation

The major factors boosting the market growth are increasing demand for minimally invasive procedures, and the rise in the prevalence of the cerebral aneurysm is anticipated to drive the market. However, the high cost of neurointerventional devices is hampering the growth of the market.

Strategic Insights

Several organic and inorganic growth strategies such as approvals, product launch, agreements, and partnerships have been witnessed in the market of Neurointerventional Devices. For instance, in May 2019, Stryker got pre-market FDA approval for Neuroform Atlas Stent System. Neuroform Atlas is only the second adjunctive stent to be given PMA clearance in combination with embolic detachable coils for the treatment of wide-neck, intracranial aneurysms.

Answers that the report acknowledges:

• Market size and growth rate during forecast period
• Key factors driving the “Neurointerventional Devices” market
• Key market trends cracking up the growth of the “Neurointerventional Devices” market
• Challenges to market growth
• Detailed company profiles of key vendor of “Neurointerventional Devices” market
• Detailed SWOT analysis of ten profiled companies
• Opportunities and threats faces by the existing vendors in Global “NEUROINTERVENTIONAL DEVICES” market
• Trending factors influencing the market in different geographical regions
• Strategic initiatives focusing the leading vendors
• PEST analysis of the market for the five major regions

Buy Now at https://www.theinsightpartners.com/buy/TIPRE00005548/

About us: –
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.